CN109123655A - A kind of special doctor's food and preparation method with three high crowd's generation meal regulatory functions - Google Patents
A kind of special doctor's food and preparation method with three high crowd's generation meal regulatory functions Download PDFInfo
- Publication number
- CN109123655A CN109123655A CN201810966090.8A CN201810966090A CN109123655A CN 109123655 A CN109123655 A CN 109123655A CN 201810966090 A CN201810966090 A CN 201810966090A CN 109123655 A CN109123655 A CN 109123655A
- Authority
- CN
- China
- Prior art keywords
- parts
- food
- mixture
- blood
- coarse powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 235000012054 meals Nutrition 0.000 title claims abstract description 22
- 230000009711 regulatory function Effects 0.000 title claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 44
- 239000000463 material Substances 0.000 claims abstract description 18
- 238000000855 fermentation Methods 0.000 claims abstract description 13
- 230000004151 fermentation Effects 0.000 claims abstract description 13
- 108090000604 Hydrolases Proteins 0.000 claims abstract description 6
- 238000004140 cleaning Methods 0.000 claims abstract description 5
- 238000000746 purification Methods 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 44
- 239000000284 extract Substances 0.000 claims description 31
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 28
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 28
- 244000302512 Momordica charantia Species 0.000 claims description 15
- 235000009811 Momordica charantia Nutrition 0.000 claims description 15
- 241000124033 Salix Species 0.000 claims description 15
- 239000011573 trace mineral Substances 0.000 claims description 15
- 235000013619 trace mineral Nutrition 0.000 claims description 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 14
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 13
- 235000010755 mineral Nutrition 0.000 claims description 13
- 239000011707 mineral Substances 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 12
- 230000002829 reductive effect Effects 0.000 claims description 12
- 235000015468 Lycium chinense Nutrition 0.000 claims description 11
- 244000241872 Lycium chinense Species 0.000 claims description 11
- 235000011347 Moringa oleifera Nutrition 0.000 claims description 11
- 241000508269 Psidium Species 0.000 claims description 11
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000011701 zinc Substances 0.000 claims description 11
- 229910052725 zinc Inorganic materials 0.000 claims description 11
- 235000008708 Morus alba Nutrition 0.000 claims description 10
- 240000000249 Morus alba Species 0.000 claims description 10
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 9
- 240000002900 Arthrospira platensis Species 0.000 claims description 9
- 244000046146 Pueraria lobata Species 0.000 claims description 9
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 9
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims description 9
- 235000019136 lipoic acid Nutrition 0.000 claims description 9
- 229940082787 spirulina Drugs 0.000 claims description 9
- 229960002663 thioctic acid Drugs 0.000 claims description 9
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 8
- 244000247747 Coptis groenlandica Species 0.000 claims description 8
- 235000010469 Glycine max Nutrition 0.000 claims description 8
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims description 8
- 235000018365 Momordica dioica Nutrition 0.000 claims description 8
- 244000197580 Poria cocos Species 0.000 claims description 8
- 235000008599 Poria cocos Nutrition 0.000 claims description 8
- 230000004913 activation Effects 0.000 claims description 8
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims description 8
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims description 7
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims description 7
- 244000179560 Prunella vulgaris Species 0.000 claims description 7
- 235000010674 Prunella vulgaris Nutrition 0.000 claims description 7
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims description 6
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 claims description 6
- 108010059892 Cellulase Proteins 0.000 claims description 5
- 229940106157 cellulase Drugs 0.000 claims description 5
- 229920001542 oligosaccharide Polymers 0.000 claims description 4
- 150000002482 oligosaccharides Chemical class 0.000 claims description 4
- 229910052573 porcelain Inorganic materials 0.000 claims description 3
- 230000002269 spontaneous effect Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 235000009827 Prunus armeniaca Nutrition 0.000 claims description 2
- 244000018633 Prunus armeniaca Species 0.000 claims description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 229910052709 silver Inorganic materials 0.000 claims description 2
- 239000004332 silver Substances 0.000 claims description 2
- 241000722948 Apocynum cannabinum Species 0.000 claims 1
- 244000179886 Moringa oleifera Species 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 23
- 235000016709 nutrition Nutrition 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 11
- 230000035764 nutrition Effects 0.000 abstract description 10
- 230000003750 conditioning effect Effects 0.000 abstract description 8
- 230000004060 metabolic process Effects 0.000 abstract description 8
- 238000005516 engineering process Methods 0.000 abstract description 6
- 102000004157 Hydrolases Human genes 0.000 abstract description 5
- 230000035622 drinking Effects 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 5
- 235000008216 herbs Nutrition 0.000 abstract description 3
- 230000010354 integration Effects 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 description 81
- 239000008280 blood Substances 0.000 description 81
- 230000000694 effects Effects 0.000 description 58
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 39
- 239000008103 glucose Substances 0.000 description 39
- 239000003814 drug Substances 0.000 description 36
- 230000036772 blood pressure Effects 0.000 description 31
- 206010012601 diabetes mellitus Diseases 0.000 description 28
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 28
- 230000002218 hypoglycaemic effect Effects 0.000 description 27
- 239000011651 chromium Substances 0.000 description 21
- 239000011669 selenium Substances 0.000 description 20
- 206010020772 Hypertension Diseases 0.000 description 19
- 150000002632 lipids Chemical class 0.000 description 18
- 244000194101 Ginkgo biloba Species 0.000 description 17
- 230000006870 function Effects 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 17
- 235000008100 Ginkgo biloba Nutrition 0.000 description 16
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 15
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 15
- 229910052804 chromium Inorganic materials 0.000 description 15
- 230000001603 reducing effect Effects 0.000 description 15
- 235000011201 Ginkgo Nutrition 0.000 description 14
- 102000004877 Insulin Human genes 0.000 description 14
- 108090001061 Insulin Proteins 0.000 description 14
- 229940125396 insulin Drugs 0.000 description 14
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 13
- 210000004204 blood vessel Anatomy 0.000 description 13
- 230000002265 prevention Effects 0.000 description 13
- 229910052711 selenium Inorganic materials 0.000 description 13
- 208000031226 Hyperlipidaemia Diseases 0.000 description 12
- 241000722949 Apocynum Species 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 11
- 241000220215 Moringa Species 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 201000001421 hyperglycemia Diseases 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 150000004676 glycans Chemical class 0.000 description 8
- 229920001282 polysaccharide Polymers 0.000 description 8
- 239000005017 polysaccharide Substances 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 230000004224 protection Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 231100000331 toxic Toxicity 0.000 description 7
- 230000002588 toxic effect Effects 0.000 description 7
- 241001061264 Astragalus Species 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 235000006533 astragalus Nutrition 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 230000006837 decompression Effects 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- -1 electuary Substances 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 230000036737 immune function Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 210000004233 talus Anatomy 0.000 description 6
- 208000024172 Cardiovascular disease Diseases 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 206010022489 Insulin Resistance Diseases 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 210000002421 cell wall Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 229930003944 flavone Natural products 0.000 description 4
- 150000002213 flavones Chemical class 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000002045 lasting effect Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 241000605447 Anemarrhena Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 229930191283 anemarrhena Natural products 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000023852 carbohydrate metabolic process Effects 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 230000003345 hyperglycaemic effect Effects 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 230000001151 other effect Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000009758 senescence Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000208688 Eucommia Species 0.000 description 2
- 208000002705 Glucose Intolerance Diseases 0.000 description 2
- 206010018473 Glycosuria Diseases 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 102000003746 Insulin Receptor Human genes 0.000 description 2
- 108010001127 Insulin Receptor Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000009098 adjuvant therapy Methods 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 210000001627 cerebral artery Anatomy 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 108010084210 citrin Proteins 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 201000009104 prediabetes syndrome Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- XWZAWHJNTHSHGD-SIDOVBMKSA-N (2S)-6-amino-N-[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]propanoyl]amino]hexanamide Polymers CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(N)=O XWZAWHJNTHSHGD-SIDOVBMKSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 241001552669 Adonis annua Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000432767 Asparagus setaceus Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 244000132059 Carica parviflora Species 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 206010066786 Diabetic keratopathy Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 208000007241 Experimental Diabetes Mellitus Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 102000018711 Facilitative Glucose Transport Proteins Human genes 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 108091052347 Glucose transporter family Proteins 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010059484 Haemodilution Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- 235000008706 Ilex latifolia Nutrition 0.000 description 1
- 244000078118 Ilex latifolia Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010049447 Tachyarrhythmia Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- BAKQMOSGYGQJOJ-RMPHRYRLSA-N [(1r,2r,3s,4r,5r)-3,4-diacetyloxy-6,8-dioxabicyclo[3.2.1]octan-2-yl] acetate Chemical class O1[C@@]2([H])OC[C@]1([H])[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2OC(C)=O BAKQMOSGYGQJOJ-RMPHRYRLSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 235000021471 food effect Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000037111 immune power Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical group 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100000149 liver necrosis Toxicity 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000008176 mammary development Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 108091006024 signal transducing proteins Proteins 0.000 description 1
- 102000034285 signal transducing proteins Human genes 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 208000021510 thyroid gland disease Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000009461 vacuum packaging Methods 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Abstract
The invention discloses a kind of special doctor's food and preparation method with three high crowd's generation meal regulatory functions, 23 kinds of " integration of drinking and medicinal herbs " food materials and 4 kinds of microelements are substantially square, it is equipped with advanced process flow, using selected, cleaning, purification, tanning is extracted, coarse powder, fine-powdered, with fermentation, hydrolases, the new technologies such as vibration of ultrasonic wave, the medical value being sufficiently extracted in original material, cooperate microelement, while guarantee that nutrition supplies comprehensively, intracorporal three high level can be adjusted significantly, improve intracorporal nutrition foundation metabolism, making one body can be safer, more precisely, more completely digest, absorb and utilize required physical nutritional, it is a big new breakthrough of a new generation's conditioning three high diseases.
Description
Technical field
The present invention relates to special doctor's food processing technology fields more particularly to a kind of with three high crowds' generation meal regulatory functions
Spy doctor's food and preparation method thereof.
Background technique
With the fast development of China's economic society, huge variation is had occurred in people's lives environment and life style,
Three high crowds steeply rise, and hypertension, hyperlipidemia, hyperglycemia have become the elderly, even the very big problem that faces of a middle-aged person, and three
The cardiovascular and cerebrovascular disease that high disease is caused is well known, and Patients with geriatric cardiovascular and cerebrovascular diseases its high illness rate, high relapse rate, high mortality and height
Disability rate occupies first of all diseases, is known as the number one killer of human health and life, is modern " rich people's disease ", and disease incidence is year by year
Rise, age of onset has tended to become younger.Illness rate is in rising trend in recent years, it has also become threatens the weight of human health and life
Factor is wanted, people's lives quality is directly affected and family's wellbeing is harmonious, hypertension, hyperlipidemia, hyperglycemia are present
Epidemic disease, lowering blood pressure and blood fat, it is hypoglycemic thus become a hot topic, as the mankind are to chemicals toxic side effect
Understanding, the prevention and treatment high for three have become the important topic of world medicine.Naturopathy is advocated in countries in the world in recent years,
Health protection with Chinese medicine food is then increasingly subject to favor, and develops a kind of Chinese herbal medicine spy doctor's food with auxiliary lower hyperlipidemia, hypertension, hyperglycemia function thus,
Blood pressure, blood lipid, the blood glucose for reducing patient while preventing three high diseases through diet, improve people's lives quality, are current
Urgent problem to be solved.
Currently, western medicine hypertension, hyperlipidemia, hyperglycemia are clinically used, however the meeting in taking Western medicine for a long time
Many adverse reactions are generated, such as use Western medicine lowering blood pressure and blood fat, hypoglycemic treatment, weak curative effect, and toxic side effect merely, it is several
All Western medicine have liver, renal toxicity, and most of Western medicine have gastrointestinal reaction, and effect is better, and toxic side effect is bigger.Long term usage
Western medicine damages liver, is impairment of the kidney, stimulating gastrointestinal road brings side effect that patient is allowed to suffer untold misery.
Damage of the Western medicine to human body is startling, and medical research shows that human body is largely taking Western medicine decompression, lipid-loweringing, hypoglycemic
While treatment, the service life of the mankind is also substantially reduced, by taking one is taken for a long time the patient of Western medicine as an example, three times a day, one time 6
Grain, the quantity that each year takes are 6570.And lowering blood pressure and blood fat, hypoglycemic Western medicine, often taking once will be to body
Organ injury 5% one 1 5%, the especially damage to kidney, liver, heart is huge.Person, human body itself are exempted within medication 2 years or more
Epidemic disease power drastically reduces, and immune function decline is obvious or loses substantially.And take Western medicine for a long time, dependence can be generated to Western medicine,
Cause dose the more to eat the more big, kind is more and more, causes some patients that need to take medicine all the life, endure all the life huge toxic side effect it
It is bitter.
Summary of the invention
Based on above-mentioned technical background, in view of the above-mentioned deficiencies in the prior art, it is an object of the present invention to overcome prior art defect,
A kind of special doctor's food and preparation method with three high crowd's generation meal regulatory functions safe and free of toxic and side effects is provided.The present invention
With strengthen immunity, lowering blood pressure and blood fat, hypoglycemic, anti-oxidation function, especially suitable for hypertension, hyperlipidemia, hyperglycemia
The dietotherapy of crowd's generation meal regulatory function and prevention and health care.
It is substantially just, to be equipped with advanced technique stream present invention uses 23 kinds of " integration of drinking and medicinal herbs " food materials and 4 kinds of microelements
Journey, and mechanical means extraction process and biological enzymolysis technology extraction process are fully utilized, it will be planted first with vibration of ultrasonic wave
The cell wall of object is broken, and allows it to discharge the benefit materials of cell interior, then extracts leaves of plants using biological enzymolysis technology
Benefit materials in cell reach the drug effect of nature lower hyperlipidemia, hypertension, hyperglycemia, and environmental protection herein in connection with scientific compatibility, and safety is healthy, effectively.
To achieve the goals above, the present invention is to realize by the following technical solutions:
A kind of special doctor's food with three high crowd's generation meal regulatory functions, the raw material including following parts by weight: soybean oligopeptide
6-18 parts of powder, 8-24 parts of hesperidine, 15-30 parts of Radix Astragali, 10-30 parts of bluish dogbane, 12-36 parts of gynostemma pentaphylla, 12-36 parts of ginkgo leaf,
16-24 parts of leaf of Moringa, 10-24 parts of balsam pear, 12-30 parts of Cortex Eucommiae, 10-24 parts of mulberry leaf, 10-24 parts of guava, 8-20 parts of Ramulus euonymi,
10-24 parts of pueraria lobata, 8-24 parts of Poria cocos, 10-36 parts of Prunella vulgaris, 10-36 parts of money willow, 12-30 parts of spirulina, faenum graecum 10-24
Part, 10-30 parts of fructus lycii, 10-36 parts of the root bark of Chinese wolf-berry, 8-18 parts of rhizoma anemarrhenae, 3-12 parts of the coptis, 6-18 parts of Radix Rehmanniae, Cr-enriched yeast 1-4
Part, 1-4 parts of Se-enriched yeast, 1-3 parts of Zinc-rich saccharomyces cerevisiae, 1-4 parts of lipoic acid.
This special doctor's food with three high crowds' generation meal regulatory functions of the invention the preparation method comprises the following steps:
Step 1: 23 kinds of food materials raw materials are selected with single-item respectively, cleaning, purification, air-dry, are respectively crushed into coarse powder, coarse powder
Granularity is 80-100 mesh, and it is spare that coarse powder mixture is made;
Step 2: the pure water of coarse powder total weight of the mixture 1-5%, stirring is added in the coarse powder mixture that step 1 obtains
Uniformly, it adds 2-8% peptide glycan hydrolase of coarse powder total weight of the mixture to carry out ultrasonic activation 30 minutes, then be added thick
The cellulase of powder mixture total weight 6-10% carries out ultrasonic activation 45 minutes, after pure water wash clean, dries, so
Afterwards, it is put into closed porcelain, temperature is under 28 degree, spontaneous fermentation 6 days, after fermentation, obtains fermentation coarse powder mixture, so
It is ground into the mixture superfine powder that granularity is 0.1 μm -10 μm afterwards;
Step 3: 5-7 times of water is added into mixture superfine powder carries out decoction 1-2h, decoct 3 times repeatedly, merges decoction liquor, warp
Reduced pressure is dried to obtain Chinese medical extract, Chinese medical extract and mineral trace element will be carried out while hot uniformly mixed, obtains
To Chinese medical extract and mineral trace element mixture;Then it is vacuum-packed, packing specification is 45-65g/ bags.
Wherein number described in all steps is parts by weight.
Wherein the granularity of coarse powder is 80-100 mesh in step 1, is to be more conducive to enzymatic hydrolysis and dry fermentation work in step 2
Skill extracts the beneficiating ingredient of Chinese medicine food materials more fully.
Wherein step 2 has carried out drying hair ferment technique, can be maximally maintained these Chinese medicine food materials medicinal ingredients, and
The purity and mouthfeel of final products can be improved.
Wherein in step 2,2-8% peptide glycan hydrolase of total weight of the mixture is added in Chinese medicine food materials coarse powder, with yeast
The cell wall constituent of bacterium cell is mainly polysaccharide, the mechanism that can be hydrolyzed under the action of poly glycosylhydrolase, thus
Extract its internal useful body trace element more fully;The cellulase of total weight of the mixture 6-10% is added,
The eucaryotic cell structure failure mechanism that can be hydrolyzed under the hydrolysis of cellulase with plant cell walls, to be beneficial
Ingredient more fully extracts.
Ultrasonic activation has also wherein been used respectively in step 2, is to allow it to break the cell wall of Chinese medicine food materials
Discharge the medical substance of cell interior.
Fermentation coarse powder mixture is wherein obtained in step 2, and it is super to be then ground to the mixture that granularity is 0.1 μm -10 μm
Fine powder, the present invention reach Ultramicro-powder by way of grinding, keep the intracellular effective component in raw material all abundant
It releases, to improve the bioavilability of material, and the mixed-powder granularity after grinding is very tiny, is more advantageous to human body
Absorption of drugs utilizes;Key is first mixed in Chinese medical extract and mineral trace element, Chinese medical extract and mineral
Interweave between matter microelement and forms a kind of reticular structure, and these superfine powders, it is diffused into Chinese medical extract and minerals is micro
It in elementary mesh structure, ideally organically blends, the active constituent in these compositions is to generate synergistic effect, phase
Mutually promote, enhance human immunity, lowering blood pressure and blood fat, it is hypoglycemic, anti-oxidant the effects of, guaranteeing that nutrition supplies comprehensively
Meanwhile, it is capable to adjust intracorporal three high level significantly, improve the metabolism of intracorporal nutrition foundation, making one body can be safer, more
Definitely, required physical nutritional is more completely digested, absorbed and utilized, is a big new breakthrough of a new generation's conditioning three high diseases.
Wherein in step 3, Chinese medical extract and mineral trace element to be carried out uniformly mixed while hot, be because want
Using residual temperature, making to interweave between Chinese medical extract and mineral trace element forms a kind of netted structure, and keeps food original
Material superfine powder under conditions of molecule energy strenuous exercise, is rapidly and uniformly diffused into Chinese medical extract and minerals when heat is abundant
Microelement interweaves in the reticular structure to be formed, and is organically blended completely, to reach final effect of the invention.
The wherein raw material of special doctor's food with three high crowd's generation meal regulatory functions provided by the present invention, is pure natural
Plant extracts, no incompatibility.
Wherein during preparation method of the invention, various raw materials, specification meets national medical standards, can be from warp
The company or manufacturer for seeking Related product are commercially available.
Wherein in step 3, packaging avoids product moisture absorption during cooling and influences the pot-life while hot;Finally
It using vacuum packaging, can effectively completely cut off air during storage, product is avoided to make moist and pollute.
The present invention have special doctor's food preparation selection soy oligosaccharides Gly-His-Lys of three high crowds generation meal regulatory functions, hesperidine,
Radix Astragali, bluish dogbane, gynostemma pentaphylla, ginkgo leaf, leaf of Moringa, balsam pear, Cortex Eucommiae, mulberry leaf, guava, Ramulus euonymi, pueraria lobata, Poria cocos, summer are withered
Grass, money willow, spirulina, faenum graecum, fructus lycii, the root bark of Chinese wolf-berry, rhizoma anemarrhenae, the coptis and Radix Rehmanniae extract and 4 kinds of needed by human body mine
Substance microelement Cr-enriched yeast, Se-enriched yeast, Zinc-rich saccharomyces cerevisiae, lipoic acid combination, are equipped with advanced process flow, using essence
Choosing, cleaning, purification, tanning are extracted, and coarse powder, fine-powdered, with fermentation, hydrolases, the new technologies such as vibration of ultrasonic wave are filled
Divide the medical value being extracted in original material, cooperate microelement, while guarantee that nutrition supplies comprehensively, can adjust significantly
Save intracorporal three high level, improve the metabolism of intracorporal nutrition foundation, make one body can it is safer, more precisely, more completely digestion,
Required physical nutritional is absorbed and utilized, is a big new breakthrough of a new generation's conditioning three high diseases.
Each material composition of special doctor's food provided by the invention, mutual cooperation booster action can be effectively reduced three high people
The effect that uric acid is reduced while the blood pressure of group, blood lipid, blood glucose, is designed specifically for three high crowds, is guaranteeing that nutrition supplies comprehensively
To while, can significantly adjust intracorporal elevated blood glucose levels, can significantly improve the metabolism of intracorporal nutrition foundation, reduction need not
The metabolic burden wanted.
Ingredient in special doctor's food preparation of the invention, being prepared into according to this field conventional preparation method can clinically receive
Suitable pharmaceutical preparations, such as electuary, granule, capsule, tablet.
The present invention has the advantage that
1. unique formula of the invention, compatibility science, improve clear mechanism.According to the pathogenesis of three high crowds, specific aim is carried out
It adjusts, systematicness conditioning, help combination.It proves that the various composition in the present invention is without any side effects through clinical trial, does not hurt
Liver, kidney, three high diseases patient can trust long-term use.
2. present composition preparation has rapid-action, good absorbing, good effect, while lowering blood pressure and blood fat, effect of reducing blood sugar
Fruit is obvious, can quickly improve three high diseases complication.
3. the ingredient in invention formulation is pure natural plant extract, conditioning environmentally friendly, green safe with nature has
It imitates, without incompatibility, has reached the purpose of " integration of drinking and medicinal herbs ".
4. the various composition in the present invention acts synergistically, mutually increase effect, reach reduction while steadily reduction by three is high
Blood pressure adjusts blood lipid, softening blood vessel, protection blood vessel and heart organ while being directed to three high diseases rehabilitation.Three high conditionings with
It has an epoch-marking significance in prevention area, is the revolution that chemically treatment is improved to biology.
5. special doctor's food formulation of the invention effectively conditioning blood sugar, control blood pressure can adjust blood lipid, used various
Material composition is pure natural plant extract.Without any side effects for human body, diabetic can trust and take, peace
It is complete reliable.
It can be obtained according in clinical laboratory data, the beneficial effect of the technology of the present invention is reducing blood glucose, blood pressure, blood lipid process
In following advantage:
One, good effect, it is quick, can quick and stable blood glucose, blood pressure lowering, reducing blood lipid.
Two, prescription science, proportion is proper, and raw material is natural, has no toxic side effect.Both three high human metabolism functions had been improved, had been increased
Strong immunity, and the digestion and absorption of liver, spleen and stomach and intestine, transportation capabilities are promoted, achieve the effect that improve three high diseases.
Three, prevention and treatment combines, and theory is advanced, and temporary solution consolidates.Various composition in the present invention mutually acts synergistically, and mutually increases
Effect, reach steadily reduce blood pressure, blood lipid, blood glucose, while adjusting blood lipid, soften blood vessel, prevent artery sclerosis, be directed to glycosuria
Sick rehabilitation protects blood vessel and heart organ simultaneously.
Four, dosage form is advanced, high in technological content, it is rapid-action, absorb thoroughly, effect it is good, hence it is evident that better than traditional formula, conditioning
Three high diseases effect is obvious.
Special doctor's food prepared composition with three high crowd's generation meal regulatory functions provided by the invention is with the following functions:
Soy oligosaccharides Gly-His-Lys: (1) it is immune system manufacture to antiviral and infection antibody, improves immune function;(2) blood drops
It is pressure, reducing blood lipid, hypoglycemic;(3) repair cell improves cell metabolism, plays protective effect on cancer risk;(4) it quickly regains one's strength of body, eliminates tired
Labor;(5) promote wound healing;(6) extra free radical in vivo is removed, is delayed senescence;(7) endocrine and nervous system are adjusted.Greatly
Beans Gly-His-Lys are easier to be absorbed by the body, it can be directly entered small intestine and be absorbed without gastro-intestinal digestion, and not by physical condition institute shadow
It rings.Beans Gly-His-Lys contain Several Active Peptides, have a variety of physiological activity, including anti-oxidant, blood pressure lowering, reduction cholesterol, drop
Blood lipid, antifatigue, enhancing is immune etc..As a kind of novel and multifunctional nourishing ingredient, soy peptide powder can be widely used in health care food
Product, infant food, sports food, fermented product and clinical nutritive preparations etc..
Bluish dogbane: calming the liver decompression.(1) liver protection, protect liver: bluish dogbane contains various bioactive components to the more of immune system
Link all has different degrees of regulating power, plays liver-protective detoxication, has apparent adjust to make humoral immunity
With.(2) lowering blood pressure and blood fat: dogbane tea contains tannin, is similar to vitamin P activity, is able to maintain or restores capillary
Normal resistance, enhance the flexibility and elasticity of blood vessel, serum cholesterol can be reduced, prevent fat deposited in vascular wall.
Tannic acid in tealeaves can inhibit blood pressure to increase, and to the effect that the blood pressure of hypertensive patient is reduced.(3) heart tonifying diuresis is auxiliary
Help blood pressure lowering: the Quercetin that bluish dogbane contains also has apparent diuresis.In addition dogbane tea contains very high magnesium, every hectogram
Containing magnesium up to 930 milligrams, and magnesium elements and pancreatic secretion pancreas islet are known as direct relationship, so drinking dogbane tea has hypertension
The effect of adjuvant treatment.(4) adjust cardio and vascular function: the flavones that bluish doghane tea contains can be by Scavenger of ROS freedom
Base plays the role of anti-arrhythmia, resists myocardial ischemia, allevating angina pectoris and improves heart function, and helps improvement cerebral ischemia, mentions
High providing brain with oxygen ability, to have certain rehabilitative action to the diseases such as heart, angiosis and hemiplegia, dementia.
Hesperidine: (1) vitamin drug can reduce the brittleness of capillary, protect capillary, prevent microvascular from going out
The effect of blood, the adjuvant treatment for high blood pressure.(2) product are citrin class medicine, for enhancing the toughness of capillary.
The derivative methyl hesperidine and citrin class medicine of hesperidine are the product recorded in Japanese " food additives official compendium "
Kind.It is the drug for treating hypertension and myocardial infarction, the raw material of pharmacy is used as in medical industry, is main group of Chinese patent drug Maitong
One of at.
Radix Astragali: pharmacological research shows that Radix Astragali has dual regulation to blood glucose, has and reinforces myocardial contractive power, diastole hat
Shape blood vessel, reduces blood pressure, and protects liver cell, reduces the effect of blood glucose.Astragalus polyose has protective effect to the cardiac muscle of diabetes, yellow
Active constituent astragalus polyose in stilbene can mitigate endoplasmic reticulum damage by improving the er stress of liver, increase glycogen and close
At enzymatic activity, increase Insulin signaling proteins synthetic quantity and activity, to play antidiabetic effect.Chinese herbal medicine astragalus can enhance and
Adjustment immune response effect has urine detumescence, prevents or reverse Urine proteins effect, can delay fibrosis, the hardening of renal tissue
Process has certain prevention effect to Progress of Diabetic Nephropathy.Astragalus in Treating diabetes recent studies have shown that astragalus polyose is
With the macromolecular compound compared with strong biological activity, astragalus polyose no matter is taken orally or be injected intraperitoneally, something lost can be significantly reduced
Weight, blood glucose and the insulin resistance index of transmissibility diabetic mice, moreover it is possible to improve impaired glucose tolerance, slim the abdomen, increase
Add insulin sensitivity, but does not influence insulin secretion.
Gynostemma pentaphylla: (1) blood pressure lowering, reducing blood lipid are hypoglycemic.(2) anti arteriosclerosis, inhibition thrombosis, treatment are cardiovascular
Disease.(3) calm the nerves and nourish one's nature, delay senescence, improve mental activity, improve cerebral function.(4) activating human body normal cell, weight-reducing
Fat, strengthening the spleen and stomach, solution fatigue, there is calmness, and migraines is treated in hypnosis, antipsycholic action.(5) anti-cancer and cancer-preventing inhibits killing cancer thin
Born of the same parents.The activity for enhancing blood of human body medium size lymphocyte, enhances the immune function of human body.(6) the secondary work of poison of hormone medicine is eliminated
With.(7) the anti-intestines of anti-inflammatory, gastric ulcer and early stage of pyogenic infection of skin.
Leaf of Moringa: (1) leaf of Moringa has hypoglycemic, lipid-loweringing, decompression, antitumor, anti-oxidant, defaecation, diuresis, expelling parasite, improvement
Sleep and other effects, long-term consumption can enhance immune function of human body, anti-aging, prevention disease.(2) leaf of Moringa can enhance immune
Power, toxin expelling, body shaping, anti-aging, anticancer simultaneously have greatly improvement effect to a variety of chronic and major disease.(3) leaf of Moringa is
Natural green food, the complete nutrients matter containing needed by human body, may replace multi-vitamins, calcium tablet, cod-liver oil etc., especially
There is good effect to hypertension, hyperlipidemia, diabetes, gout etc..(4) leaf of Moringa can assist prevention disease, improve sleep, increase
Strong memory delays senescence, and can be used to the disease for treating the privileged sites such as liver, spleen, channels and collaterals, also has treatment halitosis and wakes up
The effects of wine.
Bitter gourd polypeptide: being a kind of bioactive substance extracted from balsam pear, as a result same as insulin effective, tool
There is apparent blood sugar reducing function, is a kind of natural health-care products.(1) bitter gourd polypeptide works after entering human body 30 minutes;(2) balsam pear is more
The duration that peptide reduces blood glucose is 4-8 hours;(3) bitter gourd polypeptide is especially more prominent in the effect for controlling postprandial blood sugar;
(4) function and effect of bitter gourd polypeptide reduction blood glucose are lasting, and hypoglycemia can't occur;(5) the applicable all kinds of sugar of bitter gourd polypeptide
Urinate the people at highest risk of patient and diabetes.(6) " bitter gourd polypeptide " is a kind of pure natural plant ingredients, by activation insulin,
Insulin receptor is activated, improves insulin effective rate of utilization to adjust blood glucose, thus, blood glucose is realized according to human normal physiology
The purpose of natural law expression, and be free from side effects.The discovery and application of " bitter gourd polypeptide ", in treating diabetes and prevention area
In have an epoch-marking significance, be chemically hypoglycemic to the revolution of biological hypoglycemic.
Cortex Eucommiae: it reduces blood pressure.(1) liver protecting and kidney invigorating has apparent hepatoprotective activity, can promote the regeneration of liver cell, can be bright
The aobvious duplication for inhibiting hepatitis B virus DNA, while liver glycogen can be promoted to accumulate, increase blood-sugar content, protects liver.(2) it drops
Pressure drop rouge: the various actives composition such as rosin spirit disaccharide glycosides, peach leaf coral, chlorogenic acid, polysaccharide contained by eucommia Bark male flower has blood pressure lowering, drop
Blood fat.Test proof is efficient up to 92% or more, and is depressured persistently without any side effects.(3) enhancing is immune: eucommia Bark male flower
In the polysaccharide active material that is rich in, immunity of organisms can be enhanced, there is bidirectional modulation cellular immune function, make the immune of human body
Function effect in shape always.It is cardiovascular to simultaneously participate in adjusting, it is highly beneficial to maintenance human health.
Mulberry leaf: there is hypoglycemic effect.The blood glucose rise that ecdysterone contained by it induces a variety of methods has hypoglycemic
Effect, can promote glucose and is converted into glycogen, but do not change the blood glucose of intact animal.Mulberry leaf reduce blood pressure.Mulberry leaf
Vena femoralis injection after extracting solution is anaesthetized to dog, temporary blood pressure occur reduces, but does not influence to breathe.There are also reducing blood lipid, diuresis for mulberry leaf
Effect.
Guava: Guava Leaf itself is rich in nutritional ingredient abundant, and wherein the content of protein and Vitamin C is especially
It is high.Guava Leaf has also been rich in the nutritional ingredients such as dietary fiber, carrotene, fat.In addition contain fructose, sugarcane in Guava Leaf
The nutritional ingredients such as sugar, amino acid.Most of glycosurias have significantly scarce chromium phenomenon in patient body, and in Guava Leaf fruit and leaf
In micro " Organic Chromium " rich in, chromium is the essential trace elements of the human body, is had in normal glycometabolism and fat metabolism
There is important role.
Ginkgo leaf: (1) eliminate blood vessel rubbish, prevention cerebral thrombosis and apoplexy: studies have shown that ginkgo leaf can increase in large quantities
The blood of brain is flowed to, and accelerates the recovery after apoplexy.(2) improve brain blood supply: arteria carotis is the main thoroughfare transfused blood to brain,
After having injected ginkgo biloba p.e to animal, Flow of carotid artery is increased, and brain has obtained more blood.(3) the anti-heart
Myocardial ischemia: scientist gets up the coronary artery ligation of dog, to imitate human myocardium's infraction, when ginkgo biloba p.e is injected the heart
With the impaired animal of flesh, abnormal electrocardiogram just will appear improvement.(4) it is sticky to adjust blood lipid, attenuating blood: ginkgo leaf facilitates
Hemodilution inhibits thrombus stroke, improves blood circulation, and without any side effect.Therefore, U.S. doctor Man De claims ginkgo
It is a kind of " creative " drug.(5) adjust blood pressure: ginkgo leaf can strengthen artery sclerosis, vein and capillary, can also be with
Strengthen the resistance of peripheral vessel, eliminate extravasated blood, prevents the various obstacles of internal organ, promote function normal, these effects are in addition to by more
Secondary zoopery also can prove that, ginkgo leaf is very suitable to the patient of hypertension outside confirming from the clinical trial of various big hospital
It closes.(6) improve diabetes: in Germany or French hospital, giving discovery 95% after diabetic takes gingko leaf preparation
Above patient obtains significant improvement, and Blood Glucose significantly reduces, it is possible to reduce insulin injection amount, and to blood capillary
Pipe is again powerful, hence it is evident that improves the symptom of diabetic.(7) prevention of arterial atherosis, recovery blood vessel elasticity: ginkgo leaf can
To promote cerebral artery or peripheral vessel strong, so that the blood vessel of hardening is restored elasticity, promote the diameter of blood vessel normal, blood can be reduced
Cholesterol in liquid and prevention of arterial atherosis, function are very excellent.(8) cardioprotection: ginkgo leaf can be effectively improved blood
Liquid circulation, guarantees myocardial oxygen delivery, improves left ventricular hypertrophy, to avoid cardiopathic generation.(9) prevent senile dementia: silver
Apricot leaf can promote cerebral artery or peripheral vessel strong, be that the blood vessel of hardening restores elasticity, improve the blood vessel to narrow, it is possible thereby to
The cerebral cell recovery life for making atrophy, prevents senile dementia from generating, and improves memory, mitigates the function of feeling dizzy.(10)
Liver protection: if often taking ginkgo leaf, liver function can be promoted to give full play to.
Pueraria lobata: main component is isoflavones in legume pueraria lobata root dry root.Mild work through its multipath, multiple target point
Stick and assemble used in clinical antiplatelet, improve Hemorheology state, expansion artery blood vessel adjusts blood lipid, hypoglycemic grade side
Face embodies curative effect that is unique and determining.Microcirculation can also be improved, reduce whole blood viscosity, improve cell calcium-magnesium-Adenosine triphosphate
Glycosides enzymatic activity promotes sugar and insulin transdermal delivery.Flavones in kudzu root extract can increase brain and coronal vascular flow, blood vessel
Resistance reduces, and has hypotensive activity, and Puerarin can be such that blood glucose is decreased obviously, and hypoglycemic effect is lasting.
Poria cocos: (1) aid digestion, antiobesity action.(2) diuresis: obvious diuresis is promoted by kidney in tuckahoe teat
Water filters out rate to realize in urine.(3) enhance the effect of capillary: long-term drinking can enhance the toughness of capillary,
Prevent the rupture of capilary.
Prunella vulgaris: decompression of relieving inflammation or internal heat.Cold in nature, acrid flavour is bitter.Clearing away the liver-fire, Disperse hepatic depression, resolving sputum, hypotensive activity.Since this product has
It is good to let out irascibility effect clearly, for high blood pressure category liver heat, the high person of sun.Prunella vulgaris extract is to caused by norepinephrine
Vessel retraction has antagonism, can generate significant lasting hypotensive activity with vasodilator.It is usually used in treating high blood pressure tool
There is the hot patient of the livers such as headache, dizzy, tinnitus, dysphoria with smothery sensation, insomnia, it can compatibility cassia seed, radix scutellariae, chrysanthemum etc..Often with Ilex Latifolia Thunb, open country
Chrysanthemum compatibility antihypertensive effect can be more preferable.
Money willow: money willow polysaccharide has good hypoglycemic effect, can effectively improve hyperglycemic patients sugar tolerance, energy
Enough meet the needs of hyperglycemic patients are to sweet taste, without aggravating the state of an illness, while having in terms of hypoglycemic, lowering blood pressure and blood fat
Effect well.Thus blue or green money willow extract/money willow extract is good hypoglycemic product.In blue or green money willow extract
Blue or green money willow flavones can effectively clear intracorporal oxygen radical, improve blood circulation, reduce cholesterol, expansion of coronary artery,
Prevent cardiovascular and cerebrovascular disease.(1) hypoglycemic: money willow water extract rich in and alcohol extracting can increase vasopermeability,
Expansion artery, which improves blood circulation, reduces the purpose of blood glucose to play adjusting glycometabolism.(2) reducing blood lipid: money willow contains three
Terpene, flavones and polysaccharide etc. have very strong effect for reducing blood fat, can effectively improve intracorporal metabolism, to prevent total cholesterol
It increases.(3) blood pressure lowering: money willow can restore the structure and function of the islet cells of lesion, to increase internal peripheral group
The receptor for the pancreas islet knitted thus has haved the function that reduce blood pressure.
Spirulina: there are a variety of sugar reducing substances such as spirulina polysaccharide, magnesium, chromium in spirulina, can be through a variety of ways (as promoted
Into insulin secretion, slow down sugar absorption, promotion metabolism, anti-oxidant etc.) adjust metabolism of blood glucose.
Faenum graecum: having mitigation climacteric syndrome, treats constipation, dysentery, indigestion, controls diabetes, and it is solid to reduce gallbladder
The effects of alcohol, releive sore throat and cough, promotion mammary development and pregnancy period milk production.
Fructus lycii: there is immunological regulation, hypoglycemic, reducing blood lipid and other effects.Modern analysis shows nutrition contained by fructus lycii
Ingredient is very rich, multiple elements and 24 kinds of amino acid and multivitamin such as potassium also rich in, sodium, calcium, magnesium, zinc.
Effective component is polysaccharides.There is kidney-supplementing liver-boosting, controls the deficiency of liver-yin and kidney-yin, quench one's thirst and other effects.With reduce blood glucose, reduce blood pressure and
Lipotropic effect.The decline that Fructus lycii P.E can promote diabetes glucose lasting, to diabetic blood glucose, blood lipid liter
Height, dysphotia have improvement result.
The root bark of Chinese wolf-berry: root bark of Chinese wolf-berry decoction gives rabbit stomach-filling, first makes the raising of blood glucose short time, then persistently reduces, 4-5 hours
Most obvious, averagely reduction by 14% is reduced, then it is oral small to artificial diabetes to restore normal root bark of Chinese wolf-berry decoction for maintenance 4-8 hours
The morphosis damage of mouse islet B cell also has certain mitigation to act on.The root bark of Chinese wolf-berry is high to mouse glucose and adrenal gland disposition
Blood glucose has significant hypoglycemic effect.Pharmaceutical research shows that the root bark of Chinese wolf-berry has the function of apparent blood pressure lowering and hypoglycemic.
Rhizoma anemarrhenae: the effective component of anemarrhena asphodefoides extract includes containing a variety of steroid saponins, mucilaginous substance, niacin.Its primary efficacy: clear
Hot purging intense heat enriching yin cough caused by dryness, is quenched one's thirst, hectic fever due to yin labor heat, the diseases such as insomnia.Rhizoma anemarrhenae water logging extract, can reduce the blood glucose level of normal rabbit,
Especially alloxan diabetes rabbit is acted on more significant.Anemarrhena asphodefoides extract improves in insulin resistance drug in preparation
Using and anemarrhena asphodefoides extract preparation prevention and treatment tachyarrhythmia and essential hypertension drug in application.
The coptis: according to clinical report, coptis treatment diabetes can be such that blood glucose significantly reduces.Experiment shows the drop of berberine
Sugared mechanism has no effect on the secretion and release of insulin, nor affects on the number and affinity of Hepatocyte Insulin, but
By inhibiting gluconeogenesis and glycolysis being promoted to generate blood sugar reducing function.
Radix Rehmanniae: there is nourishing Yin and clearing heat.Blood glucose can be made significantly to decline, also can inhibit and prevent caused by adrenaline
Blood glucose rises, and can improve the hyperlipidemia of diabetic keratopathy, the hyperglycemia state of an illness.Clinical application is mostly matched when diabetes with radix rehmanniae recen
Asparagus fern, fructus lycii etc..
Cr-enriched yeast: chromium is one of safest the essential trace elements of the human body, and trace element chromium and diabetes relationship are close
It cuts.Chromium mainly reinforces insulin function to the effect of glycometabolism.In the tissue for relying on insulin, even if only milli trace chromium
Increase, insulin function will improve significantly;Chromium insufficiency of intake, body can increase the demand of insulin.Normal person
Demand is 20-50 μ g/ days, and children, pregnant woman and old man are 50-110 μ g/ days, and diabetic and obese people are 50-200 μ
G/ days.Scarce chromium is the pathogeny sexual factor for causing diabetes, atherosclerosis.Scarce chromium can be with impaired glucose tolerance, pancreas islet affinity
It reduces, the reduction of beta cell sensibility, insulin receptor reduction, blood glucose is too high or too low.Above-mentioned exception can be entangled after mending chromium
Just.Cr-enriched yeast can reduce the blood glucose of diabetic, can also improve its hypoglycemic reaction, have the dual regulation to blood glucose
Effect can be effectively controlled diabetes, eliminate the abnormal phenomenon in terms of glucose tolerance.Most safe, most efficient method is to use
Glucose tolerance factor chromium is most safe, and yeast chromium is safest at present.
Se-enriched yeast: being that selenium element is added during culture yeasts, and selenium has been absorbed and utilized in when yeast growth, make selenium with
The intracorporal protein of yeast and polysaccharide organic combine and are converted into Biological Selenium, thus eliminate chemical selenium to the toxicity of human body and
Stomach stimulation, enables that selenium is more efficient, be more safely absorbed by the body utilization.Se-enriched yeast is also highest domestic so far
The most balanced selenium-replenishing preparation of effect, most safe, nutrition.Selenium is microelement necessary to human body, selenium can prevent and inhibit tumour,
Anti-aging, the normal function for maintaining cardiovascular system, the appearance of prevention of arterial hardening and coronary heart disease.Selenium-supply can reduce liver cancer, stomach
The disease incidence of cancer, lung cancer, prostate cancer and the carcinoma of the rectum.Selenium be referred to as " treating liver necrosis protective factors ", be prevent hepatonecrosis because
One of element.Selenium can stimulate the generation of immunoglobulin, improve the various immune functions of human body.Diabetes patient's blood selenium is obvious
Lower than the blood selenium of normal person.Selenium-supply can reduce blood glucose level, while increase the activity of GPX.Selenium has insulin-like effects, energy
Promote target tissue not increase insulin level in blood while reducing blood glucose using glucose, cell membrane in terms of rouge can be stimulated
On glucose transporter transport process, this provides opportunity for the treatment of diabetes hyperinsulinemia patient.
Zinc-rich saccharomyces cerevisiae: zinc is one of the essential trace elements of the human body, and the constituent as a variety of enzymes widely participates in respectively
Kind metabolic activity.In human body, zinc is the widest essential trace element of distribution, and intracellular the most abundant microelement.
In vital movement, zinc plays " life gear " effect and DNA replication dna, rna transcription and the core of transhipment matter and energy metabolism
The required structural constituent of enzyme needed for acid synthesizes.
Lipoic acid: after human body intestinal canal absorbs, can penetrate into any one part of cell, be that human glucose metabolism follows
The necessary factor in ring.Lipoic acid energy balance blood sugar, promotes the absorption of glucose, improves the glycemic control of diabetic, into
And reduce and use insulin or hypoglycemic medicine, increase insulin sensitivity, prevents neurotrosis.Lipoic acid is mainly used for diabetes
Cacesthesia caused by peripheral neuropathy helps to treat a variety of chronic diseases such as cardiovascular disease, diabetes, liver-kidney diseases change,
The eyeground pathological changes of diabetic and the incidence of glaucoma can be reduced, is had for the improvement of diabetes complicated Myocardial damage
There is positive meaning.
The crowd for being suitable for:
1. hypertension, hyperlipidemia, hyperglycemic subject take the patient of lower hyperlipidemia, hypertension, hyperglycemia Western medicine for a long time
2. refusing the patient of Western medicine toxic side effect treatment.
3. take lower hyperlipidemia, hypertension, hyperglycemia drug for a long time, generation side effect, and the patient that cannot normally feed.
4. needing the patient that three high initial symptoms are adjusted using special doctor's food.
5. the special the three high patients that cannot normally feed.
Specific embodiment
To be easy to understand the technical means, the creative features, the aims and the efficiencies achieved by the present invention, below with reference to
Specific embodiment, the present invention is further explained.
Embodiment 1
A kind of special doctor's food with three high crowd's generation meal regulatory functions, the raw material including following parts by weight: soybean oligopeptide
8 parts of powder, 8 parts of hesperidine, 18 parts of Radix Astragali, 12 parts of bluish dogbane, 18 parts of gynostemma pentaphylla, 20 parts of ginkgo leaf, 18 parts of leaf of Moringa, balsam pear 18
Part, 18 parts of Cortex Eucommiae, 15 parts of mulberry leaf, 15 parts of guava, 10 parts of Ramulus euonymi, 12 parts of pueraria lobata, 10 parts of Poria cocos, 12 parts of Prunella vulgaris, money
12 parts of willow, 14 parts of spirulina, 16 parts of faenum graecum, 12 parts of fructus lycii, 10 parts of the root bark of Chinese wolf-berry, 10 parts of rhizoma anemarrhenae, 4 parts of the coptis, 8 parts of Radix Rehmanniae,
1.2 parts of Cr-enriched yeast, 2 parts of Se-enriched yeast, 1.1 parts of Zinc-rich saccharomyces cerevisiae, 1.5 parts of lipoic acid.
Embodiment 2
A kind of special doctor's food with three high crowd's generation meal regulatory functions, the raw material including following parts by weight: soybean oligopeptide
10 parts of powder, 10 parts of hesperidine, 24 parts of Radix Astragali, 16 parts of bluish dogbane, 20 parts of gynostemma pentaphylla, 24 parts of ginkgo leaf, 20 parts of leaf of Moringa, balsam pear
22.5 parts, 20 parts of Cortex Eucommiae, 20 parts of mulberry leaf, 20 parts of guava, 10 parts of Ramulus euonymi, 14 parts of pueraria lobata, 10.5 parts of Poria cocos, Prunella vulgaris 14
Part, 16 parts of money willow, 16 parts of spirulina, 18 parts of faenum graecum, 14 parts of fructus lycii, 18 parts of the root bark of Chinese wolf-berry, 10.5 parts of rhizoma anemarrhenae, 4 parts of the coptis,
10 parts of Radix Rehmanniae, 1.4 parts of Cr-enriched yeast, 2.2 parts of Se-enriched yeast, 1.4 parts of Zinc-rich saccharomyces cerevisiae, 1.8 parts of lipoic acid.
Embodiment 3
Special doctor's food with three high crowd's generation meal regulatory functions, the raw material including following parts by weight: soy oligosaccharides Gly-His-Lys 14
Part, 12 parts of hesperidine, 30 parts of Radix Astragali, 18 parts of bluish dogbane, 28 parts of gynostemma pentaphylla, 30 parts of ginkgo leaf, 28 parts of leaf of Moringa, 30 parts of balsam pear,
28 parts of Cortex Eucommiae, 28 parts of mulberry leaf, 28 parts of guava, 12 parts of Ramulus euonymi, 18 parts of pueraria lobata, 12 parts of Poria cocos, 16 parts of Prunella vulgaris, money willow 18
Part, 16 parts of spirulina, 20 parts of faenum graecum, 18 parts of fructus lycii, 22 parts of the root bark of Chinese wolf-berry, 12 parts of rhizoma anemarrhenae, 4.5 parts of the coptis, 14 parts of Radix Rehmanniae, it is rich
2 parts of chromium yeast, 2.5 parts of Se-enriched yeast, 1.8 parts of Zinc-rich saccharomyces cerevisiae, 2.4 parts of lipoic acid.
Embodiment 1,2,3 the preparation method comprises the following steps:
Step 1: original 24 taste Chinese medicine food materials are selected with single-item respectively, cleaning, purification, air-dry, are respectively crushed into coarse powder, slightly
The granularity of powder is 80-100 mesh, and it is spare that coarse powder mixture is made;
Step 2: the pure water of coarse powder total weight of the mixture 1-5%, stirring is added in the coarse powder mixture that step 1 obtains
Uniformly, it adds 2-8% peptide glycan hydrolase of coarse powder total weight of the mixture to carry out ultrasonic activation 30 minutes, then be added thick
The cellulase of powder mixture total weight 6-10% carries out ultrasonic activation 45 minutes, after pure water wash clean, dries, so
Afterwards, it is put into closed porcelain, temperature is under 28 degree, spontaneous fermentation 6 days, after fermentation, obtains fermentation coarse powder mixture, so
It is ground into the mixture superfine powder that granularity is 0.1 μm -10 μm afterwards;
Step 3: 5-7 times of water is added into mixture superfine powder carries out decoction 1-2h, decoct 3 times repeatedly, merges decoction liquor, warp
Reduced pressure is dried to obtain Chinese medical extract, Chinese medical extract and mineral trace element will be carried out while hot uniformly mixed, obtains
To Chinese medical extract and mineral trace element mixture;Then it is vacuum-packed, packing specification is 45-65g/ bags.
Experimental data related for the present invention is as follows
1. experiment purpose
Study special doctor's food effect with three high crowd's generation meal regulatory functions of the invention.
2. experimental method
Subject presses recommended dose daily and eats sample, continuous 3 months edible.Do not change original eating habit during test,
Normal diet.
3. experimental design
300 three high volunteers of random selection are divided into 3 groups, every group 100, eat the spy of 1-3 of embodiment of the present invention preparation respectively
Food is cured, following patient is excluded: malignant disease is (1) suffered from, such as tumour, severe cardiac, liver, kidney diaseases;Thyroid disease;(2) test
Start once to take hypoglycemic, decompression, fat-reducing medicament in first 1 month.
By above-mentioned 300 subjects, early, middle and late half an hour after meal eats special doctor's food prepared by the present invention daily, continuously
Edible 3 months, remaining time not dietary restriction did not changed lifestyles.
The effect of each group is evaluated in this experiment using patient's Self-control method.
3.1 Testing index
Before the experiment with experiment at the end of, each group detects following body index: blood pressure, glucose, total cholesterol, glycerol
Three esters, high density cholesterol, low density cholesterol.
The variation that patient tests any blood markers of front and back own control and biochemical indicator be greater than 1% be it is effective, be greater than 5%
It is effective, it is invalid less than 1%.
4. experimental result
The results are shown in Table 1 for the specific experiment of each group.
1 lower hyperlipidemia, hypertension, hyperglycemia experimental result of table
Embodiment 1, number of cases 100, effective number of cases 60, effective number of cases 37, invalid number of cases 3, total effective rate 97.0%.
Embodiment 2, number of cases 100, effective number of cases 58, effective number of cases 39, invalid number of cases 3, total effective rate 97.0%.
Embodiment 3, number of cases 100, effective number of cases 59, effective number of cases 36, invalid number of cases 5, total effective rate 95.0%.
From above-mentioned data: special doctor's food decompression prepared by the present invention, lipid-loweringing, hypoglycemic, which have, to improve significantly.
5. experiment conclusion
Special doctor's food prepared by the present invention, each raw material mutual cooperation, collective effect under specific proportion have significant drop blood
Pressure, reducing blood lipid, hypoglycemic effect.Above-described embodiment is not to implementation just for the sake of clearly demonstrating example
The restriction of mode.For those of ordinary skill in the art, can also make on the basis of the above description it is other not
With the variation and variation of form.There is no necessity and possibility to exhaust all the enbodiments.And it is extended from this aobvious
And the variation and variation being clear to are still within the protection scope of the invention.
It is above-mentioned referring to embodiment to a kind of special doctor's food with three high crowds generation meal regulatory functions and preparation method thereof into
Capable detailed description is illustrative without being restrictive, and can enumerate several embodiments according to limited range, therefore
Change and modification in the case where not departing from present general inventive concept should belong within protection scope of the present invention.
Claims (5)
1. a kind of special doctor's food with three high crowd's generation meal regulatory functions, it is characterised in that: the original including following parts by weight
Material: 6-18 parts of soy oligosaccharides Gly-His-Lys, 8-24 parts of hesperidine, 15-30 parts of Radix Astragali, 10-30 parts of bluish dogbane, 12-36 parts of gynostemma pentaphylla, silver
12-36 parts of apricot leaf, 16-24 parts of leaf of Moringa, 10-24 parts of balsam pear, 12-30 parts of Cortex Eucommiae, 10-24 parts of mulberry leaf, 10-24 parts of guava,
8-20 parts of Ramulus euonymi, 10-24 parts of pueraria lobata, 8-24 parts of Poria cocos, 10-36 parts of Prunella vulgaris, 10-36 parts of money willow, spirulina 12-30
Part, 10-24 parts of faenum graecum, 10-30 parts of fructus lycii, 10-36 parts of the root bark of Chinese wolf-berry, 8-18 parts of rhizoma anemarrhenae, 3-12 parts of the coptis, Radix Rehmanniae 6-18
Part, 1-4 parts of Cr-enriched yeast, 1-4 parts of Se-enriched yeast, 1-3 parts of Zinc-rich saccharomyces cerevisiae, 1-4 parts of lipoic acid.
2. a kind of preparation method of special doctor's food with three high crowd's generation meal regulatory functions according to claim 1,
It is characterized in that: Step 1: 23 kinds of food materials raw materials are selected with single-item respectively, cleaning, purification, air-dry, be respectively crushed into coarse powder, making
It is spare at coarse powder mixture;Step 2: coarse powder total weight of the mixture 1-5% is added in the coarse powder mixture that step 1 obtains
Pure water, stir evenly, add 2-8% peptide glycan hydrolase of coarse powder total weight of the mixture carry out ultrasonic activation 30 divide
Clock, the cellulase that coarse powder total weight of the mixture 6-10% is then added carry out ultrasonic activation 45 minutes, dry with pure washing
It after net, dry, then, is put into closed porcelain, temperature is under 28 degree, spontaneous fermentation 6 days, after fermentation, it is thick to obtain fermentation
Powder mixture is then ground to mixture superfine powder;Step 3: 5-7 times of water is added into mixture superfine powder carries out decoction 1-
2h is decocted 3 times repeatedly, merges decoction liquor, Chinese medical extract is dried to obtain through being concentrated under reduced pressure, Chinese medical extract and 4 kinds of mineral
Matter microelement is uniformly mixed, and obtains Chinese medical extract and mineral trace element mixture;Then it is vacuum-packed, packaging rule
Lattice are 45-65g/ bags.
3. a kind of preparation method of special doctor's food with three high crowd's generation meal regulatory functions according to claim 2,
Be characterized in that: the granularity of coarse powder is 80-100 mesh in step 1.
4. a kind of preparation method of special doctor's food with three high crowd's generation meal regulatory functions according to claim 2,
It is characterized in that: being ground into the mixture superfine powder that granularity is 0.1 μm -10 μm in step 2.
5. a kind of preparation method of special doctor's food with three high crowd's generation meal regulatory functions according to claim 2,
Be characterized in that: Chinese medical extract and mineral trace element will carry out uniformly mixed while hot in step 3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810966090.8A CN109123655A (en) | 2018-08-23 | 2018-08-23 | A kind of special doctor's food and preparation method with three high crowd's generation meal regulatory functions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810966090.8A CN109123655A (en) | 2018-08-23 | 2018-08-23 | A kind of special doctor's food and preparation method with three high crowd's generation meal regulatory functions |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109123655A true CN109123655A (en) | 2019-01-04 |
Family
ID=64790979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810966090.8A Pending CN109123655A (en) | 2018-08-23 | 2018-08-23 | A kind of special doctor's food and preparation method with three high crowd's generation meal regulatory functions |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109123655A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112675284A (en) * | 2021-01-08 | 2021-04-20 | 深圳市中康生物制药有限公司 | Recombinant diabetes composite plant polypeptide and preparation and application thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101496580A (en) * | 2008-01-28 | 2009-08-05 | 中国食品发酵工业研究院 | Special diet and foodstuffs formula containing small peptide for diabetic |
CN101507494A (en) * | 2009-02-12 | 2009-08-19 | 刘志伟 | Special diet food for patient with hyperlipidemia and hypertension |
CN101584706A (en) * | 2009-04-07 | 2009-11-25 | 北京利千秋科技发展有限公司 | Pharmaceutical composition used for reducing blood sugar and blood fat and treating diabetes |
CN101940620A (en) * | 2010-09-14 | 2011-01-12 | 广州市和藤医药研究开发有限公司 | Medicinal composition for treating diabetes mellitus and application thereof |
CN104524146A (en) * | 2014-12-04 | 2015-04-22 | 赵光学 | Traditional Chinese medicine composition for prevention and adjuvant treatment of hypertensive, hyperlipidemia and hyperglycemia and application of traditional Chinese medicine composition |
CN105963514A (en) * | 2016-05-25 | 2016-09-28 | 邓院子 | Traditional Chinese medicine product for treating diabetes and preparation method |
CN106912921A (en) * | 2017-01-18 | 2017-07-04 | 恩施硒域传奇健康管理有限公司 | A kind of diabetes full nutrition formula food |
CN108185441A (en) * | 2018-01-17 | 2018-06-22 | 江苏优曦特斯生物制品有限公司 | A kind of formula food for treating diabetes and preparation method thereof |
-
2018
- 2018-08-23 CN CN201810966090.8A patent/CN109123655A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101496580A (en) * | 2008-01-28 | 2009-08-05 | 中国食品发酵工业研究院 | Special diet and foodstuffs formula containing small peptide for diabetic |
CN101507494A (en) * | 2009-02-12 | 2009-08-19 | 刘志伟 | Special diet food for patient with hyperlipidemia and hypertension |
CN101584706A (en) * | 2009-04-07 | 2009-11-25 | 北京利千秋科技发展有限公司 | Pharmaceutical composition used for reducing blood sugar and blood fat and treating diabetes |
CN101940620A (en) * | 2010-09-14 | 2011-01-12 | 广州市和藤医药研究开发有限公司 | Medicinal composition for treating diabetes mellitus and application thereof |
CN104524146A (en) * | 2014-12-04 | 2015-04-22 | 赵光学 | Traditional Chinese medicine composition for prevention and adjuvant treatment of hypertensive, hyperlipidemia and hyperglycemia and application of traditional Chinese medicine composition |
CN105963514A (en) * | 2016-05-25 | 2016-09-28 | 邓院子 | Traditional Chinese medicine product for treating diabetes and preparation method |
CN106912921A (en) * | 2017-01-18 | 2017-07-04 | 恩施硒域传奇健康管理有限公司 | A kind of diabetes full nutrition formula food |
CN108185441A (en) * | 2018-01-17 | 2018-06-22 | 江苏优曦特斯生物制品有限公司 | A kind of formula food for treating diabetes and preparation method thereof |
Non-Patent Citations (4)
Title |
---|
夏丽等: "《临床医疗诊断》", 31 January 2010, 内蒙古科学技术出版社 * |
张明: "《三高吃什么宜忌速查全书》", 29 February 2016, 天津科学技术出版社 * |
张虹: "《趣话中药》", 30 September 2012, 人民军医出版社 * |
迟玉杰: "《保健食品学》", 31 May 2016, 中国轻工业出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112675284A (en) * | 2021-01-08 | 2021-04-20 | 深圳市中康生物制药有限公司 | Recombinant diabetes composite plant polypeptide and preparation and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (en) | Health-care food for preventing diabetes | |
CN102988638B (en) | Cyclocarya paliurus blood-lipid and blood-sugar reducing health-care tea and preparation method thereof | |
CN1170588A (en) | Pure natural plant human life energy nutritive substrate | |
CN103446385B (en) | Traditional Chinese medicine preparation for treating diabetic complications | |
CN107929420A (en) | Improve energy and blood of human body function and improve the Chinese medicine composition and detection method of immunity | |
CN101612315A (en) | A kind of compound Chinese medicinal preparation that is used to adjust function of human body | |
CN108524814A (en) | A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose | |
CN105963514A (en) | Traditional Chinese medicine product for treating diabetes and preparation method | |
CN103719497A (en) | Gynostemma pentaphylla fat-reducing and weight-losing health-care tea and preparation method thereof | |
CN109730180A (en) | A kind of lowering blood pressure and blood fat, hypoglycemic composition and preparation method thereof and tea bag | |
CN106244371A (en) | A kind of blood sugar lowering Rhizoma Polygonati grape health care wine and production technology thereof | |
CN103099833A (en) | Soft capsule helpful for relieving sports fatigue and delaying aging and preparation method thereof | |
CN104663975A (en) | Acanthopanax health tea for decreasing sugar and lipid and preparation method for acanthopanax health tea | |
CN107751993A (en) | A kind of antifatigue cream taste and preparation method thereof | |
CN105708970B (en) | A kind of health food with function of blood sugar reduction | |
CN106176953A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja, Fructus Momordicae and Folium Mori | |
CN110051815A (en) | A kind of auxiliary hyperglycemic food ball and preparation method thereof | |
CN104206595A (en) | Blood lipid and blood glucose reducing Chinese wolfberry root-bark health care tea and preparation method thereof | |
CN101336965B (en) | Chinese prepared medicine for improving sugar tolerance and reducing blood sugar and preparation method thereof | |
CN109123655A (en) | A kind of special doctor's food and preparation method with three high crowd's generation meal regulatory functions | |
CN104645015A (en) | Traditional Chinese medicine compound preparation for treating vascular dementia and preparation method of traditional Chinese medicine compound preparation | |
CN105535486A (en) | Medicine for treating liver depression and qi stagnation type postpartum hypogalactia and preparation method thereof | |
CN101062283B (en) | Tea for reducing blood sugar and its preparing method | |
CN107158299A (en) | It is a kind of that there is composition of enhancing learning memory function and preparation method thereof | |
CN107812115A (en) | A kind of Chinese medicine composition for treating diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190122 Address after: 518000, 1001, 10th floor, Jiaye Plaza, 2055 Bixin Road, Longgang Street, Longgang District, Shenzhen City, Guangdong Province Applicant after: Doctor Biotechnology (Shenzhen) Co., Ltd. Address before: 453634 Nanliu Village, Jitun Town, Huixian City, Xinxiang City, Henan Province, 198 Applicant before: Liu Deping |
|
TA01 | Transfer of patent application right | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190104 |
|
WD01 | Invention patent application deemed withdrawn after publication |